Literature DB >> 34471630

Neurofibromatosis 2: Primary Modality of Hearing Rehabilitation with Cochlear Implant.

Dathathri Anantaramaiah Halyur1, Praveen H Rayanagoudar1, Apurva Kumar2, Sunil Narayan Dutt3.   

Abstract

Auditory Brainstem Implants have been recommended as the gold standard in hearing rehabilitation of Neurofibromatosis Type 2 patients who lose hearing completely in both the ears and the cochlear nerves are not stimulable. Some patients have undergone cochlear implantation, in whom the cochlear nerve was spared during surgery or have undergone stereotactic radiotherapy preserving the function of the cochlear nerve. Here we report a case in whom we chose cochlear implantation prior to any definitive treatment for the tumour itself during the 'wait and watch' period. The reasons in favour of this approach have been discussed in this article. Post switch-on the implant is benefitting the patient satisfactorily and she is on regular follow up for monitoring the bilateral tumours. © Association of Otolaryngologists of India 2021.

Entities:  

Keywords:  Cochlear implantation; Deafness rehabilitation; Neurofibromatosis Type 2; Transtympanic EABR

Year:  2021        PMID: 34471630      PMCID: PMC8364601          DOI: 10.1007/s12070-020-02321-x

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  25 in total

1.  Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.

Authors:  Matthew L Carlson; Joseph T Breen; Colin L Driscoll; Michael J Link; Brian A Neff; René H Gifford; Charles W Beatty
Journal:  Otol Neurotol       Date:  2012-07       Impact factor: 2.311

2.  Influence of ionizing radiation on nucleus 24 cochlear implants.

Authors:  T Klenzner; F Knapp; F Röhner; E von Wallenberg; H Mauch; P Pedersen; A Aschendorff; R Laszig; J Lutterbach
Journal:  Otol Neurotol       Date:  2005-07       Impact factor: 2.311

3.  Safety study of the Cochlear Nucleus 24 device with internal magnet in the 1.5 Tesla magnetic resonance imaging scanner.

Authors:  Samuel P Gubbels; Sean O McMenomey
Journal:  Laryngoscope       Date:  2006-06       Impact factor: 3.325

4.  Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2.

Authors:  Y Kida; T Kobayashi; T Tanaka; Y Mori
Journal:  Surg Neurol       Date:  2000-04

5.  Promontory electrical stimulation in postoperative acoustic tumor patients.

Authors:  P R Lambert; R A Ruth; J F Thomas
Journal:  Laryngoscope       Date:  1992-07       Impact factor: 3.325

6.  Gamma knife surgery of vestibular schwannomas: volumetric dosimetry correlations to hearing loss suggest stria vascularis devascularization as the mechanism of early hearing loss.

Authors:  P Ashley Wackym; Christina L Runge-Samuelson; John J Nash; David M Poetker; Katherine Albano; Joseph Bovi; Michelle A Michel; David R Friedland; Yong-ran Zhu; Maureen T Hannley
Journal:  Otol Neurotol       Date:  2010-12       Impact factor: 2.311

7.  Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature.

Authors:  Anandh Balasubramaniam; Patrick Shannon; Mojgan Hodaie; Normand Laperriere; Howard Michaels; Abhijit Guha
Journal:  Neuro Oncol       Date:  2007-08-17       Impact factor: 12.300

8.  Cochlear implants in the management of bilateral acoustic neuromas.

Authors:  R A Hoffman; D Kohan; N L Cohen
Journal:  Am J Otol       Date:  1992-11

9.  The influence of ionizing radiation on the CLARION 1.2 cochlear implant during radiation therapy.

Authors:  R Baumann; A Lesinski-Schiedat; J E Goldring; D Gnadeberg; K L Rittmann; R D Battmer; J Karstens; T Lenarz
Journal:  Am J Otol       Date:  1999-01

10.  Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.

Authors:  Brian A Neff; R Mark Wiet; John M Lasak; Noel L Cohen; Harold C Pillsbury; Richard T Ramsden; D Bradley Welling
Journal:  Laryngoscope       Date:  2007-06       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.